High Potency Classics' Nutritive Cleanser 2 oz / 59 ml Lather a quarter-sized amount in hands and gently massage onto damp skin
For more grab-and-go ideas, see our Top 10 Healthy Lunch Ideas
Roughly eight times over the ceiling
Get 10% OFF with this code: 1storder Our Product Categories Save 15% Epithalon is a synthetic tetrapeptide based on a naturally occurring substance called epithalamin, which is produced in the pineal gland
Sources Eli Lilly, "Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial" (May 21, 2026) TRIUMPH-1 topline: 28.3% at 80 weeks, 30.3% at 104 weeks, 45.3% achieving 30%+ weight loss Eli Lilly, "Lilly's triple agonist, retatrutide, successful in two additional Phase 3 obesity trials" (July 23, 2026) TRIUMPH-2 (20.8% at 12 mg, A1C up to -1.6%) and TRIUMPH-3 (22.6% at 12 mg) topline, plus the stated plan to submit a BLA to the FDA in Q1 2027 ClinicalTrials.gov NCT05929066 (TRIUMPH-1) Phase 3, status Completed, primary completion April 6, 2026 Eli Lilly Q4 2025 earnings call transcript (February 4, 2026) confirmed regulatory submission planned for 2026 Eli Lilly press releases and investor communications ClinicalTrials.gov (TRIUMPH program trial registrations) Jastreboff AM, et al
In summary, while both medications offer benefits for type 2 diabetes and weight management, tirzepatides dual receptor agonism may provide enhanced glycemic control and weight loss outcomes compared to semaglutide
